Madeline Griffith

Statistics

Publications

Citations

H-Index

Active since

2022

Affiliations

University of California, San Francisco(Current)

Madeline Griffith is an author at University of California, San Francisco specializing in metastatic liver disease treatment, pharmacology, and chemotherapy.

ORCID

Publications per year

2022–2023

Publications

Phase I prospective trial of TAS-102 (trifluridine and tipiracil) and radioembolization with 90Y resin microspheres for chemo-refractory colorectal liver metastases

Nicholas Fidelman, Chloé E. Atreya, Madeline Griffith et al. · BMC Cancer · 2022 · 13 citations · Full text

Medicine, Oncology, Pharmacology +15

Modulation of myeloid and T cells in vivo by Bruton’s tyrosine kinase inhibitor ibrutinib in patients with metastatic pancreatic ductal adenocarcinoma

Meenal Sinha, Courtney B. Betts, Li Zhang et al. · Journal for ImmunoTherapy of Cancer · 2023 · 11 citations · Full text

Pharmacy, Immunology, Pharmacology +17

1–2 of 2